Skip to main content
Erschienen in: Die Gynäkologie 1/2022

22.12.2021 | Tachykarde Herzrhythmusstörungen | Leitthema

Fetale Arrhythmien – ein Update

verfasst von: Prof. Dr. Ulrich Gembruch

Erschienen in: Die Gynäkologie | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Zusammenfassung

Länger anhaltende Arrhythmien werden bei 1–2 % der Feten nachgewiesen. Differenziert werden fetale Arrhythmien mittels M‑mode- und Doppler-Echokardiographie. Überwachung und Therapie sind der vorliegenden Arrhythmie anzupassen. Bei Tachyarrhythmien werden transplazentar Digoxin, Flecainid, Sotalol und Amiodaron eingesetzt, wobei Flecainid bei atrioventrikulären Reentry-Tachykardien mehr und mehr primär eingesetzt wird. Beim inflammatorisch bedingten kompletten AV(atrioventrikulären)-Block (congenital complete heart block, CCHB) durch maternale Anti-SSA/Ro-Antikörper ist eine generelle transplazentare Behandlung mit hochdosierten fluorierten Kortikosteroiden zur Eindämmung einer begleitenden Myokarditis aufgrund des Nebenwirkungsprofils nicht indiziert; sie ist allenfalls bei Feten mit Zeichen kardialer Dysfunktion und kardialer Fibrose zu erwägen. Zur Prävention sollte im Hochrisikokollektiv (Wiederholungsrisiko bei vorherigem Kind mit CCHB 16–19 %) die tägliche Gabe von 400 mg Hydroxychloroquin (HCQ) bereits vor der 10. Schwangerschaftswoche (SSW) erfolgen, wodurch das Risiko halbiert werden kann. Derzeit nicht indiziert ist eine generelle HCQ bei allen Schwangeren mit nachweisbaren Anti-SSA/Ro-Antikörpern zwecks Prävention, da aufgrund des geringen Risikos von 1–2 % die „number needed to treat“ (NNT) 100+ beträgt und relevante kardiale Ereignisse aufgrund der HCQ-bedingten QT-Zeit-Verlängerung möglich erscheinen. Die lange Zeit empfohlene sehr aufwendige wöchentlich echokardiographische Messung der fetalen AV-Zeit mit dem Ziel, einen AV-Block I. Grades zu erkennen und durch Behandlung mit Dexamethason das Auftreten einer CCHB zu verhindern, hat sich mittlerweile als ineffektiv erweisen.
Literatur
1.
Zurück zum Zitat Alsaied T, Baskar S, Fares M et al (2017) First-line antiarrhythmic transplacental treatment for fetal tachyarrhythmia: a systematic review and meta-analysis. J Am Heart Assoc 6:e7164 PubMedPubMedCentralCrossRef Alsaied T, Baskar S, Fares M et al (2017) First-line antiarrhythmic transplacental treatment for fetal tachyarrhythmia: a systematic review and meta-analysis. J Am Heart Assoc 6:e7164 PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat Andersson NW, Skov L, Andersen JT (2020) Fetal safety of chloroquine and hydroxychloroquine use during pregnancy: a nationwide cohort study. Rheumatology 60:2317–2326 CrossRef Andersson NW, Skov L, Andersen JT (2020) Fetal safety of chloroquine and hydroxychloroquine use during pregnancy: a nationwide cohort study. Rheumatology 60:2317–2326 CrossRef
3.
Zurück zum Zitat Bar-Cohen Y, Loeb GE, Pruetz JD et al (2015) Preclinical testing and optimization of a novel fetal micropacemaker. Heart Rhythm 12:1683–1690 PubMedPubMedCentralCrossRef Bar-Cohen Y, Loeb GE, Pruetz JD et al (2015) Preclinical testing and optimization of a novel fetal micropacemaker. Heart Rhythm 12:1683–1690 PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Bartin R, Maltret A, Nicloux M et al (2021) Outcomes of sustained fetal tachyarrhythmias after transplacental treatment. Heart Rhythm 2:160–167 CrossRef Bartin R, Maltret A, Nicloux M et al (2021) Outcomes of sustained fetal tachyarrhythmias after transplacental treatment. Heart Rhythm 2:160–167 CrossRef
5.
Zurück zum Zitat Baschat AA, Gembruch U, Knöpfle G, Hansmann M (1999) First-trimester fetal heart block: a marker for cardiac anomaly. Ultrasound Obstet Gynecol 14:311–314 PubMedCrossRef Baschat AA, Gembruch U, Knöpfle G, Hansmann M (1999) First-trimester fetal heart block: a marker for cardiac anomaly. Ultrasound Obstet Gynecol 14:311–314 PubMedCrossRef
6.
Zurück zum Zitat Bérard A, Sheehy O, Zhao JP et al (2021) Chloroquine and hydroxychloroquine use during pregnancy and the risk of adverse pregnancy outcomes using real-world evidence. Front Pharmacol 12:722511 PubMedPubMedCentralCrossRef Bérard A, Sheehy O, Zhao JP et al (2021) Chloroquine and hydroxychloroquine use during pregnancy and the risk of adverse pregnancy outcomes using real-world evidence. Front Pharmacol 12:722511 PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Berg C, Geipel A, Smrcek J et al (2003) Prenatal diagnosis of cardiosplenic syndromes: a 10-year experience. Ultrasound Obstet Gynecol 22:451–459 PubMedCrossRef Berg C, Geipel A, Smrcek J et al (2003) Prenatal diagnosis of cardiosplenic syndromes: a 10-year experience. Ultrasound Obstet Gynecol 22:451–459 PubMedCrossRef
8.
Zurück zum Zitat Berg C, Geipel A, Kohl T et al (2005) Atrioventricular block detected in fetal life: associated anomalies and potential prognostic markers. Ultrasound Obstet Gynecol 26:4–15 PubMedCrossRef Berg C, Geipel A, Kohl T et al (2005) Atrioventricular block detected in fetal life: associated anomalies and potential prognostic markers. Ultrasound Obstet Gynecol 26:4–15 PubMedCrossRef
9.
Zurück zum Zitat Berg C, Geipel A, Kamil D et al (2005) The syndrome of left isomerism: sonographic findings and outcomes in prenatally diagnosed cases. J Ultrasound Med 24:921–931 PubMedCrossRef Berg C, Geipel A, Kamil D et al (2005) The syndrome of left isomerism: sonographic findings and outcomes in prenatally diagnosed cases. J Ultrasound Med 24:921–931 PubMedCrossRef
10.
Zurück zum Zitat Berg C, Gottschalk I, Geipel A, Gembruch U (2013) Diagnosis and therapy of fetal arrhythmias 1—methods of rhythm diagnosis, extrasystole and bradyarrhythias. Ultraschall Med 34:114–127 PubMedCrossRef Berg C, Gottschalk I, Geipel A, Gembruch U (2013) Diagnosis and therapy of fetal arrhythmias 1—methods of rhythm diagnosis, extrasystole and bradyarrhythias. Ultraschall Med 34:114–127 PubMedCrossRef
11.
Zurück zum Zitat Berg C, Gottschalk I, Gembruch U, Geipel A (2013) Diagnosis and therapy of fetal arrhythmia part 2—Fetal tachyarrhythmias and their intrauterine treatment. Ultraschall Med 34:322–331 PubMedCrossRef Berg C, Gottschalk I, Gembruch U, Geipel A (2013) Diagnosis and therapy of fetal arrhythmia part 2—Fetal tachyarrhythmias and their intrauterine treatment. Ultraschall Med 34:322–331 PubMedCrossRef
12.
Zurück zum Zitat Bergman G, Eliasson H, Mohlkert LA et al (2012) Progression to first-degree heart block in preschool children exposed in utero to maternal anti-SSA/Ro52 autoantibodies. Acta Paediatr 101:488–493 PubMedCrossRef Bergman G, Eliasson H, Mohlkert LA et al (2012) Progression to first-degree heart block in preschool children exposed in utero to maternal anti-SSA/Ro52 autoantibodies. Acta Paediatr 101:488–493 PubMedCrossRef
13.
14.
Zurück zum Zitat Ciardulli A, D’Antonio F, Magro-Malosso ER et al (2018) Maternal steroid therapy for fetuses with second-degree immune-mediated congenital atrioventricular block: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 97:787–794 PubMedCrossRef Ciardulli A, D’Antonio F, Magro-Malosso ER et al (2018) Maternal steroid therapy for fetuses with second-degree immune-mediated congenital atrioventricular block: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 97:787–794 PubMedCrossRef
15.
Zurück zum Zitat Clur SB, Vink AS, Etheridge SP et al (2018) Left ventricular isovolumetric relaxation time is prolonged in fetal long-QT syndrome. Circ Arrhythm Electrophysiol 11:e5797 PubMedCrossRef Clur SB, Vink AS, Etheridge SP et al (2018) Left ventricular isovolumetric relaxation time is prolonged in fetal long-QT syndrome. Circ Arrhythm Electrophysiol 11:e5797 PubMedCrossRef
16.
Zurück zum Zitat Cuneo BF (2019) Fetal bradycardia. In: Yagel S, Silverman NH, Gembruch U (Hrsg) Fetal cardiology: embryology, genetics, physiology, echocardiographic evaluation, diagnosis, and perinatal management of cardiac diseases. CRC Press, Taylor & Francis Group, Boca Raton, S 513–529 Cuneo BF (2019) Fetal bradycardia. In: Yagel S, Silverman NH, Gembruch U (Hrsg) Fetal cardiology: embryology, genetics, physiology, echocardiographic evaluation, diagnosis, and perinatal management of cardiac diseases. CRC Press, Taylor & Francis Group, Boca Raton, S 513–529
17.
Zurück zum Zitat Cuneo BF, Bitant S, Strasburger JF et al (2019) Assessment of atrioventricular conduction by echocardiography and magnetocardiography in normal and anti-Ro/SSA-antibody-positive pregnancies. Ultrasound Obstet Gynecol 54:625–633 PubMedPubMedCentralCrossRef Cuneo BF, Bitant S, Strasburger JF et al (2019) Assessment of atrioventricular conduction by echocardiography and magnetocardiography in normal and anti-Ro/SSA-antibody-positive pregnancies. Ultrasound Obstet Gynecol 54:625–633 PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Cuneo BF, Buyon JP (2019) Keeping upbeat to prevent the heartbreak of anti-Ro/SSA pregnancy. Ultrasound Obstet Gynecol 54:7–9 PubMedCrossRef Cuneo BF, Buyon JP (2019) Keeping upbeat to prevent the heartbreak of anti-Ro/SSA pregnancy. Ultrasound Obstet Gynecol 54:7–9 PubMedCrossRef
19.
Zurück zum Zitat Cuneo BF, Etheridge SP, Horigome H et al (2013) Arrhythmia phenotype during fetal life suggests long-QT syndrome genotype: risk stratification of perinatal long-QT syndrome. Circ Arrhythm Electrophysiol 6:946–951 PubMedPubMedCentralCrossRef Cuneo BF, Etheridge SP, Horigome H et al (2013) Arrhythmia phenotype during fetal life suggests long-QT syndrome genotype: risk stratification of perinatal long-QT syndrome. Circ Arrhythm Electrophysiol 6:946–951 PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Cuneo BF, Sonesson SE, Levasseur S et al (2018) Home monitoring for fetal heart rhythm during anti-Ro pregnancies. J Am Coll Cardiol 72:1940–1951 PubMedCrossRef Cuneo BF, Sonesson SE, Levasseur S et al (2018) Home monitoring for fetal heart rhythm during anti-Ro pregnancies. J Am Coll Cardiol 72:1940–1951 PubMedCrossRef
21.
Zurück zum Zitat Cuneo BF, Strasburger JF, Yu S et al (2013) In utero diagnosis of long QT syndrome by magnetocardiography. Circulation 128:2183–2191 PubMedCrossRef Cuneo BF, Strasburger JF, Yu S et al (2013) In utero diagnosis of long QT syndrome by magnetocardiography. Circulation 128:2183–2191 PubMedCrossRef
22.
Zurück zum Zitat Eliasson H, Sonesson SE, Sharland G et al (2011) Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patients. Circulation 124:1919–1926 PubMedCrossRef Eliasson H, Sonesson SE, Sharland G et al (2011) Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patients. Circulation 124:1919–1926 PubMedCrossRef
23.
Zurück zum Zitat Fredi M, Andreoli L, Bacco B et al (2019) First report of the Italian registry on immune-mediated congenital heart block (Lu.Ne Registry). Front Cardiovasc Med 6:11 PubMedPubMedCentralCrossRef Fredi M, Andreoli L, Bacco B et al (2019) First report of the Italian registry on immune-mediated congenital heart block (Lu.Ne Registry). Front Cardiovasc Med 6:11 PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Friedman DM, Kim MY, Copel JA et al (2009) Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study. Am J Cardiol 103:1102–1106 PubMedPubMedCentralCrossRef Friedman DM, Kim MY, Copel JA et al (2009) Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study. Am J Cardiol 103:1102–1106 PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Friedman DM, Kim M, Costedoat-Chalumeau N et al (2020) Electrocardiographic QT intervals in infants exposed to hydroxychloroquine throughout gestation. Circ Arrhythm Electrophysiol 13:e8686 PubMedPubMedCentralCrossRef Friedman DM, Kim M, Costedoat-Chalumeau N et al (2020) Electrocardiographic QT intervals in infants exposed to hydroxychloroquine throughout gestation. Circ Arrhythm Electrophysiol 13:e8686 PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Friedman DM, Llanos C, Izmirly PM et al (2010) Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial. Arthritis Rheum 62:1138–1146 PubMedPubMedCentralCrossRef Friedman DM, Llanos C, Izmirly PM et al (2010) Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial. Arthritis Rheum 62:1138–1146 PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Gembruch U (2019) Fetal tachyarrhythmia. In: Yagel S, Silverman N, Gembruch U (Hrsg) Fetal cardiology, 3. Aufl. CRC Press, Taylor & Francis, Boca Raton, S 530–547 Gembruch U (2019) Fetal tachyarrhythmia. In: Yagel S, Silverman N, Gembruch U (Hrsg) Fetal cardiology, 3. Aufl. CRC Press, Taylor & Francis, Boca Raton, S 530–547
28.
Zurück zum Zitat Gembruch U, Bald R, Hansmann M (1990) Die farbkodierte M‑mode-Doppler-Echokardiographie bei der Diagnostik fetaler Arrhythmien. Geburtshilfe Frauenheilkd 50:286–290 PubMedCrossRef Gembruch U, Bald R, Hansmann M (1990) Die farbkodierte M‑mode-Doppler-Echokardiographie bei der Diagnostik fetaler Arrhythmien. Geburtshilfe Frauenheilkd 50:286–290 PubMedCrossRef
29.
Zurück zum Zitat Gembruch U, Hansmann M, Redel DA, Bald (1988) Intrauterine therapy of fetal tachyarrhythmias: intraperitoneal administration of antiarrhythmic drugs to the fetus in fetal tachyarrhythmias with severe hydrops fetalis. J Perinat Med 16:39–44 PubMedCrossRef Gembruch U, Hansmann M, Redel DA, Bald (1988) Intrauterine therapy of fetal tachyarrhythmias: intraperitoneal administration of antiarrhythmic drugs to the fetus in fetal tachyarrhythmias with severe hydrops fetalis. J Perinat Med 16:39–44 PubMedCrossRef
30.
Zurück zum Zitat Gembruch U, Hansmann M, Redel DA et al (1989) Fetal complete heart block: antenatal diagnosis, significance and management. Eur J Obstet Gynecol Reprod Biol 31:9–22 PubMedCrossRef Gembruch U, Hansmann M, Redel DA et al (1989) Fetal complete heart block: antenatal diagnosis, significance and management. Eur J Obstet Gynecol Reprod Biol 31:9–22 PubMedCrossRef
31.
Zurück zum Zitat Gembruch U, Krapp M, Baumann P (1995) Changes of venous blood flow velocity waveforms in fetuses with supraventricular tachycardia. Ultrasound Obstet Gynecol 5:394–399 PubMedCrossRef Gembruch U, Krapp M, Baumann P (1995) Changes of venous blood flow velocity waveforms in fetuses with supraventricular tachycardia. Ultrasound Obstet Gynecol 5:394–399 PubMedCrossRef
32.
Zurück zum Zitat Gembruch U, Krapp M, Germer U, Baumann P (1999) Venous Doppler in the sonographic surveillance of fetuses with supraventricular tachycardia. Eur J Obstet Gynecol Reprod Biol 84:187–192 PubMedCrossRef Gembruch U, Krapp M, Germer U, Baumann P (1999) Venous Doppler in the sonographic surveillance of fetuses with supraventricular tachycardia. Eur J Obstet Gynecol Reprod Biol 84:187–192 PubMedCrossRef
33.
Zurück zum Zitat Gembruch U, Manz M, Bald R et al (1989) Repeated intravascular treatment with amiodarone in a fetus with refractory supraventricular tachycardia and hydrops fetalis. Am Heart J 118:1335–1338 PubMedCrossRef Gembruch U, Manz M, Bald R et al (1989) Repeated intravascular treatment with amiodarone in a fetus with refractory supraventricular tachycardia and hydrops fetalis. Am Heart J 118:1335–1338 PubMedCrossRef
34.
Zurück zum Zitat Gembruch U, Redel DA, Bald R, Hansmann M (1993) Longitudinal study in 18 cases of fetal supraventricular tachycardia: Doppler-echocardiographic findings and pathophysiological implications. Am Heart J 125:1290–1301 PubMedCrossRef Gembruch U, Redel DA, Bald R, Hansmann M (1993) Longitudinal study in 18 cases of fetal supraventricular tachycardia: Doppler-echocardiographic findings and pathophysiological implications. Am Heart J 125:1290–1301 PubMedCrossRef
35.
Zurück zum Zitat Gest AL, Bair DK, Vander Straten MC (1993) Thoracic duct lymph flow in fetal sheep with increased venous pressure from electrically induced tachycardia. Biol Neonate 64:325–330 PubMedCrossRef Gest AL, Bair DK, Vander Straten MC (1993) Thoracic duct lymph flow in fetal sheep with increased venous pressure from electrically induced tachycardia. Biol Neonate 64:325–330 PubMedCrossRef
36.
Zurück zum Zitat Gest AL, Martin CG, Moise AA, Hansen TN (1990) Reversal of venous blood flow with atrial tachycardia and hydrops in fetal sheep. Pediatr Res 28:223–226 PubMedCrossRef Gest AL, Martin CG, Moise AA, Hansen TN (1990) Reversal of venous blood flow with atrial tachycardia and hydrops in fetal sheep. Pediatr Res 28:223–226 PubMedCrossRef
37.
Zurück zum Zitat Groves AMM, Allan LD, Rosenthal E (1995) Therapeutic trial of sympathomimetics in three cases of complete heart block in the fetus. Circulation 92:3394–3396 PubMedCrossRef Groves AMM, Allan LD, Rosenthal E (1995) Therapeutic trial of sympathomimetics in three cases of complete heart block in the fetus. Circulation 92:3394–3396 PubMedCrossRef
38.
Zurück zum Zitat Guettrot-Imbert G, Cohen L, Fermont L et al (2011) A new presentation of neonatal lupus: 5 cases of isolated mild endocardial fibroelastosis associated with maternal anti-Ro/SSA and anti-La/SSB antibodies. J Rheumatol 38:378–386 PubMedCrossRef Guettrot-Imbert G, Cohen L, Fermont L et al (2011) A new presentation of neonatal lupus: 5 cases of isolated mild endocardial fibroelastosis associated with maternal anti-Ro/SSA and anti-La/SSB antibodies. J Rheumatol 38:378–386 PubMedCrossRef
39.
Zurück zum Zitat Hansmann M, Gembruch U, Bald R et al (1991) Fetal tachyarrhythmias: transplacental and direct treatment of the fetus—a report of sixty fetuses. Ultrasound Obstet Gynecol 1:162–170 PubMedCrossRef Hansmann M, Gembruch U, Bald R et al (1991) Fetal tachyarrhythmias: transplacental and direct treatment of the fetus—a report of sixty fetuses. Ultrasound Obstet Gynecol 1:162–170 PubMedCrossRef
40.
Zurück zum Zitat van der Heijden LB, Oudijk MA, Manten GT et al (2013) Sotalol as first-line treatment for fetal tachycardia and neonatal follow-up. Ultrasound Obstet Gynecol 42:285–293 PubMedCrossRef van der Heijden LB, Oudijk MA, Manten GT et al (2013) Sotalol as first-line treatment for fetal tachycardia and neonatal follow-up. Ultrasound Obstet Gynecol 42:285–293 PubMedCrossRef
41.
Zurück zum Zitat Hill GD, Kovach JR, Saudek DE et al (2017) Transplacental treatment of fetal tachycardia: a systematic review and meta-analysis. Prenat Diagn 37:1076–1083 PubMedCrossRef Hill GD, Kovach JR, Saudek DE et al (2017) Transplacental treatment of fetal tachycardia: a systematic review and meta-analysis. Prenat Diagn 37:1076–1083 PubMedCrossRef
42.
Zurück zum Zitat Ho SY, Esscher E, Anderson RH, Michaelsson M (1986) Anatomy of congenital complete heart block and relation to maternal anti-Ro-antibodies. Am J Cardiol 58:291–294 PubMedCrossRef Ho SY, Esscher E, Anderson RH, Michaelsson M (1986) Anatomy of congenital complete heart block and relation to maternal anti-Ro-antibodies. Am J Cardiol 58:291–294 PubMedCrossRef
43.
Zurück zum Zitat Ho SY, Fagg N, Anderson RH et al (1992) Disposition of the atrioventricular conduction tissues in the heart with isomerism of the atrial appendages: its relation to congenital complete heart block. J Am Coll Cardiol 20:904–910 PubMedCrossRef Ho SY, Fagg N, Anderson RH et al (1992) Disposition of the atrioventricular conduction tissues in the heart with isomerism of the atrial appendages: its relation to congenital complete heart block. J Am Coll Cardiol 20:904–910 PubMedCrossRef
44.
Zurück zum Zitat Hutter D, Silverman ED, Jaeggi ET (2010) The benefits of transplacental treatment of isolated congenital complete heart block associated with maternal anti-Ro/SSA antibodies: a review. Scand J Immunol 72:235–241 PubMedCrossRef Hutter D, Silverman ED, Jaeggi ET (2010) The benefits of transplacental treatment of isolated congenital complete heart block associated with maternal anti-Ro/SSA antibodies: a review. Scand J Immunol 72:235–241 PubMedCrossRef
45.
Zurück zum Zitat Huybrechts KF, Bateman BT, Zhu Y et al (2021) Hydroxychloroquine early in pregnancy and risk of birth defects. Am J Obstet Gynecol 224:290.e1–290.e22 CrossRef Huybrechts KF, Bateman BT, Zhu Y et al (2021) Hydroxychloroquine early in pregnancy and risk of birth defects. Am J Obstet Gynecol 224:290.e1–290.e22 CrossRef
46.
Zurück zum Zitat Izmirly PM, Costedoat-Chalumeau N, Pisoni CN et al (2012) Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus. Circulation 126:76–82 PubMedPubMedCentralCrossRef Izmirly PM, Costedoat-Chalumeau N, Pisoni CN et al (2012) Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus. Circulation 126:76–82 PubMedPubMedCentralCrossRef
47.
Zurück zum Zitat Izmirly P, Kim M, Friedman DM et al (2020) Hydroxychloroquine to prevent recurrent congenital heart block in fetuses of anti-SSA/Ro-positive mothers. J Am Coll Cardiol 76:292–302 PubMedPubMedCentralCrossRef Izmirly P, Kim M, Friedman DM et al (2020) Hydroxychloroquine to prevent recurrent congenital heart block in fetuses of anti-SSA/Ro-positive mothers. J Am Coll Cardiol 76:292–302 PubMedPubMedCentralCrossRef
48.
Zurück zum Zitat Izmirly PM, Saxena A, Sahl SK et al (2016) Assessment of fluorinated steroids to avert progression and mortality in anti-SSA/Ro-associated cardiac injury limited to the fetal conduction system. Ann Rheum Dis 75:1161–1165 PubMedCrossRef Izmirly PM, Saxena A, Sahl SK et al (2016) Assessment of fluorinated steroids to avert progression and mortality in anti-SSA/Ro-associated cardiac injury limited to the fetal conduction system. Ann Rheum Dis 75:1161–1165 PubMedCrossRef
49.
Zurück zum Zitat Jaeggi ET (2019) Electrophysiology for the perinataologist. In: Yagel S, Silverman NH, Gembruch U (Hrsg) Fetal cardiology: embryology, genetics, physiology, echocardiographic evaluation, diagnosis, and perinatal management of cardiac diseases. CRC Press, Taylor & Francis Group, Boca Raton, S 504–514 Jaeggi ET (2019) Electrophysiology for the perinataologist. In: Yagel S, Silverman NH, Gembruch U (Hrsg) Fetal cardiology: embryology, genetics, physiology, echocardiographic evaluation, diagnosis, and perinatal management of cardiac diseases. CRC Press, Taylor & Francis Group, Boca Raton, S 504–514
50.
Zurück zum Zitat Jaeggi ET, Carvalho JS, De Groot E et al (2011) Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study. Circulation 124:1747–1754 PubMedCrossRef Jaeggi ET, Carvalho JS, De Groot E et al (2011) Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study. Circulation 124:1747–1754 PubMedCrossRef
51.
Zurück zum Zitat Jaeggi ET, Fouron JC, Silverman ED et al (2004) Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation 110:1542–1548 PubMedCrossRef Jaeggi ET, Fouron JC, Silverman ED et al (2004) Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation 110:1542–1548 PubMedCrossRef
52.
Zurück zum Zitat Jaeggi ET, Hornberger LK, Smallhorn JF, Fouron JC (2005) Prenatal diagnosis of complete atrioventricular block associated with structural heart disease: combined experience of two tertiary care centers and review of the literature. Ultrasound Obstet Gynecol 26:16–21 PubMedCrossRef Jaeggi ET, Hornberger LK, Smallhorn JF, Fouron JC (2005) Prenatal diagnosis of complete atrioventricular block associated with structural heart disease: combined experience of two tertiary care centers and review of the literature. Ultrasound Obstet Gynecol 26:16–21 PubMedCrossRef
53.
Zurück zum Zitat Jaeggi E, Laskin C, Hamilton R et al (2010) The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus: a prospective study of 186 antibody-exposed fetuses and infants. J Am Coll Cardiol 55:2778–2784 PubMedCrossRef Jaeggi E, Laskin C, Hamilton R et al (2010) The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus: a prospective study of 186 antibody-exposed fetuses and infants. J Am Coll Cardiol 55:2778–2784 PubMedCrossRef
54.
Zurück zum Zitat Jaeggi ET, Silverman ED, Laskin C et al (2011) Prolongation of the atrioventricular conduction in fetuses exposed to maternal anti-Ro/SSA and anti-La/SSB antibodies did not predict progressive heart block. A prospective observational study on the effects of maternal antibodies on 165 fetuses. J Am Coll Cardiol 57:1487–1492 PubMedCrossRef Jaeggi ET, Silverman ED, Laskin C et al (2011) Prolongation of the atrioventricular conduction in fetuses exposed to maternal anti-Ro/SSA and anti-La/SSB antibodies did not predict progressive heart block. A prospective observational study on the effects of maternal antibodies on 165 fetuses. J Am Coll Cardiol 57:1487–1492 PubMedCrossRef
55.
Zurück zum Zitat Jobe AH, Goldenberg RL (2018) Antenatal corticosteroids: an assessment of anticipated benefits and potential risks. Am J Obstet Gynecol 219:62–74 PubMedCrossRef Jobe AH, Goldenberg RL (2018) Antenatal corticosteroids: an assessment of anticipated benefits and potential risks. Am J Obstet Gynecol 219:62–74 PubMedCrossRef
56.
Zurück zum Zitat Jouannic JM, Delahaye S, Fermont L et al (2003) Fetal supraventricular tachycardia: a role for amiodarone as second-line therapy. Prenat Diagn 23:152–156 PubMedCrossRef Jouannic JM, Delahaye S, Fermont L et al (2003) Fetal supraventricular tachycardia: a role for amiodarone as second-line therapy. Prenat Diagn 23:152–156 PubMedCrossRef
57.
Zurück zum Zitat Kan N, Silverman ED, Kingdom J et al (2017) Serial echocardiography for immune-mediated heart disease in the fetus: results of a risk-based prospective surveillance strategy. Prenat Diagn 37:375–382 PubMedCrossRef Kan N, Silverman ED, Kingdom J et al (2017) Serial echocardiography for immune-mediated heart disease in the fetus: results of a risk-based prospective surveillance strategy. Prenat Diagn 37:375–382 PubMedCrossRef
58.
Zurück zum Zitat Ko JK, Deal BJ, Strasburger JF et al (1992) Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am J Cardiol 69:1028–1031 PubMedCrossRef Ko JK, Deal BJ, Strasburger JF et al (1992) Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am J Cardiol 69:1028–1031 PubMedCrossRef
59.
Zurück zum Zitat Kothari DS, Skinner JR (2006) Neonatal tachycardias: an update. Arch Dis Child Fetal Neonatal Ed 91:136–144 CrossRef Kothari DS, Skinner JR (2006) Neonatal tachycardias: an update. Arch Dis Child Fetal Neonatal Ed 91:136–144 CrossRef
60.
Zurück zum Zitat Krapp M, Baschat AA, Gembruch U et al (2002) Flecainide in the intrauterine treatment of fetal suparventricular tachycardia. Ultrasound Obstet Gynecol 19:158–164 PubMedCrossRef Krapp M, Baschat AA, Gembruch U et al (2002) Flecainide in the intrauterine treatment of fetal suparventricular tachycardia. Ultrasound Obstet Gynecol 19:158–164 PubMedCrossRef
61.
Zurück zum Zitat Krapp M, Gembruch U, Baumann P (1997) Venous blood flow pattern suggesting tachycardia-induced cardiomyopathy in the fetus. Ultrasound Obstet Gynecol 10:32–40 PubMedCrossRef Krapp M, Gembruch U, Baumann P (1997) Venous blood flow pattern suggesting tachycardia-induced cardiomyopathy in the fetus. Ultrasound Obstet Gynecol 10:32–40 PubMedCrossRef
62.
Zurück zum Zitat Krapp M, Kohl T, Simpson JM et al (2003) Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart 89:913–917 PubMedPubMedCentralCrossRef Krapp M, Kohl T, Simpson JM et al (2003) Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart 89:913–917 PubMedPubMedCentralCrossRef
63.
Zurück zum Zitat Krummholz A, Gottschalk I, Geipel A et al (2021) Prenatal diagnosis, associated findings and postnatal outcome in fetuses with congenitally corrected transposition of the great arteries. Arch Gynecol Obstet 303:1469–1481 PubMedCrossRef Krummholz A, Gottschalk I, Geipel A et al (2021) Prenatal diagnosis, associated findings and postnatal outcome in fetuses with congenitally corrected transposition of the great arteries. Arch Gynecol Obstet 303:1469–1481 PubMedCrossRef
64.
Zurück zum Zitat Lazzerini PE, Laghi-Pasini F, Boutjdir M, Capecchi PL (2021) Anti-Ro/SSA antibodies and the autoimmune long-QT syndrome. Front Med 8:730161 CrossRef Lazzerini PE, Laghi-Pasini F, Boutjdir M, Capecchi PL (2021) Anti-Ro/SSA antibodies and the autoimmune long-QT syndrome. Front Med 8:730161 CrossRef
65.
Zurück zum Zitat Lin PH, Wu HH, Tsai HD, Hsieh CT (2016) Successful treatment of atrial flutter by repeated intraperitoneal and intra-amniotic injections of amiodarone in a fetus with hydrops. Taiwan J Obstet Gynecol 55:434–436 PubMedCrossRef Lin PH, Wu HH, Tsai HD, Hsieh CT (2016) Successful treatment of atrial flutter by repeated intraperitoneal and intra-amniotic injections of amiodarone in a fetus with hydrops. Taiwan J Obstet Gynecol 55:434–436 PubMedCrossRef
66.
Zurück zum Zitat Limaye MA, Buyon JP, Cuneo BF, Mehta-Lee SS (2020) A review of fetal and neonatal consequences of maternal systemic lupus erythematosus. Prenat Diagn 40:1066–1076 PubMedCrossRef Limaye MA, Buyon JP, Cuneo BF, Mehta-Lee SS (2020) A review of fetal and neonatal consequences of maternal systemic lupus erythematosus. Prenat Diagn 40:1066–1076 PubMedCrossRef
67.
Zurück zum Zitat Michaelsson M, Engle MA (1972) Congenital complete heart block: an international study of the natural history. Cardiovasc Clin 4:85–101 PubMed Michaelsson M, Engle MA (1972) Congenital complete heart block: an international study of the natural history. Cardiovasc Clin 4:85–101 PubMed
68.
Zurück zum Zitat Mitchell JL, Cuneo BF, Etheridge SP et al (2012) Fetal heart rate predictors of long QT syndrome. Circulation 126:2688–2695 PubMedCrossRef Mitchell JL, Cuneo BF, Etheridge SP et al (2012) Fetal heart rate predictors of long QT syndrome. Circulation 126:2688–2695 PubMedCrossRef
69.
Zurück zum Zitat Miyoshi T, Maeno Y, Hamasaki T et al (2019) Antenatal therapy for fetal supraventricular tachyarrhythmias: multicenter trial. J Am Coll Cardiol 74:874–885 PubMedCrossRef Miyoshi T, Maeno Y, Hamasaki T et al (2019) Antenatal therapy for fetal supraventricular tachyarrhythmias: multicenter trial. J Am Coll Cardiol 74:874–885 PubMedCrossRef
70.
Zurück zum Zitat Mofors J, Eliasson H, Ambrosi A et al (2019) Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero. Ann Rheum Dis 78:696–703 PubMedCrossRef Mofors J, Eliasson H, Ambrosi A et al (2019) Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero. Ann Rheum Dis 78:696–703 PubMedCrossRef
71.
Zurück zum Zitat Naheed ZJ, Strasburger JF, Deal BJ et al (1996) Fetal tachycardia: mechanisms and predictors of hydrops fetalis. J Am Coll Cardiol 27:1736–1740 PubMedCrossRef Naheed ZJ, Strasburger JF, Deal BJ et al (1996) Fetal tachycardia: mechanisms and predictors of hydrops fetalis. J Am Coll Cardiol 27:1736–1740 PubMedCrossRef
72.
Zurück zum Zitat Narang K, Rose CH, Johnson JN et al (2020) Rare case of fetal permanent junctional reciprocating tachycardia refractory to prenatal antiarrhythmic therapy. Mayo Clin Proc Innov Qual Outcomes 4:810–814 PubMedPubMedCentralCrossRef Narang K, Rose CH, Johnson JN et al (2020) Rare case of fetal permanent junctional reciprocating tachycardia refractory to prenatal antiarrhythmic therapy. Mayo Clin Proc Innov Qual Outcomes 4:810–814 PubMedPubMedCentralCrossRef
73.
Zurück zum Zitat Phoon CKL, Kim MY, Buyon JP, Friedman DM (2012) Finding the “PR-fect” solution: what is the best tool to measure fetal cardiac PR intervals for the detection and possible treatment of early conduction disease? Congenit Heart Dis 7:349–360 PubMedPubMedCentralCrossRef Phoon CKL, Kim MY, Buyon JP, Friedman DM (2012) Finding the “PR-fect” solution: what is the best tool to measure fetal cardiac PR intervals for the detection and possible treatment of early conduction disease? Congenit Heart Dis 7:349–360 PubMedPubMedCentralCrossRef
74.
Zurück zum Zitat Pisoni CN, Brucato A, Ruffatti A et al (2010) Failure of intravenous immunoglobulin to prevent congenital heart block: findings of a multicenter, prospective, observational study. Arthritis Rheum 62:1147–1152 PubMedCrossRef Pisoni CN, Brucato A, Ruffatti A et al (2010) Failure of intravenous immunoglobulin to prevent congenital heart block: findings of a multicenter, prospective, observational study. Arthritis Rheum 62:1147–1152 PubMedCrossRef
75.
Zurück zum Zitat Pruetz JD, Miller JC, Loeb GE et al (2019) Prenatal diagnosis and management of congenital complete heart block. Birth Defects Res 111:380–388 PubMedPubMedCentralCrossRef Pruetz JD, Miller JC, Loeb GE et al (2019) Prenatal diagnosis and management of congenital complete heart block. Birth Defects Res 111:380–388 PubMedPubMedCentralCrossRef
76.
Zurück zum Zitat Rein AJJT, O’Donnell C, Geva T et al (2002) Use of tissue velocity imaging in the diagnosis of fetal cardiac arrhythmias. Circulation 106:1827–1833 PubMedCrossRef Rein AJJT, O’Donnell C, Geva T et al (2002) Use of tissue velocity imaging in the diagnosis of fetal cardiac arrhythmias. Circulation 106:1827–1833 PubMedCrossRef
77.
Zurück zum Zitat Saito M, Silverman E, Golding F et al (2021) Effects of transplacental dexamethasone therapy on fetal immune-mediated complete heart block. Fetal Diagn Ther 48:183–188 PubMedCrossRef Saito M, Silverman E, Golding F et al (2021) Effects of transplacental dexamethasone therapy on fetal immune-mediated complete heart block. Fetal Diagn Ther 48:183–188 PubMedCrossRef
78.
Zurück zum Zitat Sethi N, Funamoto K, Ingbar C et al (2020) Noninvasive fetal electrocardiography in the diagnosis of long QT syndrome: a case series. Fetal Diagn Ther 47:711–716 PubMedCrossRef Sethi N, Funamoto K, Ingbar C et al (2020) Noninvasive fetal electrocardiography in the diagnosis of long QT syndrome: a case series. Fetal Diagn Ther 47:711–716 PubMedCrossRef
79.
Zurück zum Zitat Shokrzadeh A, Maltret A, Morel N et al (2021) Longitudinal analysis of fetal ventricular rate for risk stratification in immune congenital heart block. Fetal Diagn Ther 48:1–8 CrossRefPubMed Shokrzadeh A, Maltret A, Morel N et al (2021) Longitudinal analysis of fetal ventricular rate for risk stratification in immune congenital heart block. Fetal Diagn Ther 48:1–8 CrossRefPubMed
80.
Zurück zum Zitat Spinale FG, Tanaka R, Crawford FA, Zile MR (1992) Changes in myocardial blood flow during development of and recovery from tachycardia-induced cardiomyopathy. Circulation 85:717–729 CrossRef Spinale FG, Tanaka R, Crawford FA, Zile MR (1992) Changes in myocardial blood flow during development of and recovery from tachycardia-induced cardiomyopathy. Circulation 85:717–729 CrossRef
81.
Zurück zum Zitat Sonesson SE, Ambrosi A, Wahren-Herlenius M (2019) Benefits of fetal echocardiographic surveillance in pregnancies at risk of congenital heart block: Single-center study of 212 anti-Ro52-positive pregnancies. Ultrasound Obstet Gynecol 54:87–95 PubMedCrossRef Sonesson SE, Ambrosi A, Wahren-Herlenius M (2019) Benefits of fetal echocardiographic surveillance in pregnancies at risk of congenital heart block: Single-center study of 212 anti-Ro52-positive pregnancies. Ultrasound Obstet Gynecol 54:87–95 PubMedCrossRef
82.
Zurück zum Zitat Sonesson SE, Salomonsson S, Jacobsson LA et al (2004) Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies. Arthritis Rheum 50:1253–1261 PubMedCrossRef Sonesson SE, Salomonsson S, Jacobsson LA et al (2004) Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies. Arthritis Rheum 50:1253–1261 PubMedCrossRef
83.
Zurück zum Zitat Sridharan S, Sullivan I, Tomek V et al (2016) Flecainide versus digoxin for fetal supraventricular tachycardia: comparison of two drug treatment protocols. Heart Rhythm 13:1913–1919 PubMedCrossRef Sridharan S, Sullivan I, Tomek V et al (2016) Flecainide versus digoxin for fetal supraventricular tachycardia: comparison of two drug treatment protocols. Heart Rhythm 13:1913–1919 PubMedCrossRef
84.
Zurück zum Zitat Stevens DC, Hilliard JK, Schreiner RL et al (1982) Supraventricular tachycardia with edema, ascites, and hydrops in fetal sheep. Am J Obstet Gynecol 142:316–322 PubMedCrossRef Stevens DC, Hilliard JK, Schreiner RL et al (1982) Supraventricular tachycardia with edema, ascites, and hydrops in fetal sheep. Am J Obstet Gynecol 142:316–322 PubMedCrossRef
85.
Zurück zum Zitat Stirnemann J, Maltret A, Haydar A et al (2018) Successful in utero transesophageal pacing for severe drug-resistant tachyarrhythmia. Am J Obstet Gynecol 219:320–325 PubMedCrossRef Stirnemann J, Maltret A, Haydar A et al (2018) Successful in utero transesophageal pacing for severe drug-resistant tachyarrhythmia. Am J Obstet Gynecol 219:320–325 PubMedCrossRef
86.
Zurück zum Zitat Strand S, Strasburger JF, Cuneo BF, Wakai RT (2020) Complex and novel arrhythmias precede stillbirth in fetuses with de novo long QT syndrome. Circ Arrhythm Electrophysiol 13:e8082 PubMedPubMedCentralCrossRef Strand S, Strasburger JF, Cuneo BF, Wakai RT (2020) Complex and novel arrhythmias precede stillbirth in fetuses with de novo long QT syndrome. Circ Arrhythm Electrophysiol 13:e8082 PubMedPubMedCentralCrossRef
88.
Zurück zum Zitat Strasburger JF, Cuneo BF, Michon MM et al (2004) Amiodarone therapy for drug-refractory fetal tachycardia. Circulation 109:375–379 PubMedCrossRef Strasburger JF, Cuneo BF, Michon MM et al (2004) Amiodarone therapy for drug-refractory fetal tachycardia. Circulation 109:375–379 PubMedCrossRef
89.
Zurück zum Zitat Strasburger JF, Wacker-Gussmann A (2020) Congenital heart block in subsequent pregnancies of SSA/Ro-positive mothers: cutting recurrence in half. J Am Coll Cardiol 76:303–305 PubMedPubMedCentralCrossRef Strasburger JF, Wacker-Gussmann A (2020) Congenital heart block in subsequent pregnancies of SSA/Ro-positive mothers: cutting recurrence in half. J Am Coll Cardiol 76:303–305 PubMedPubMedCentralCrossRef
90.
Zurück zum Zitat Strizek B, Berg C, Gottschalk I et al (2016) High-dose flecainide is the most effective treatment of fetal supraventricular tachycardia. Heart Rhythm 13:1283–1288 PubMedCrossRef Strizek B, Berg C, Gottschalk I et al (2016) High-dose flecainide is the most effective treatment of fetal supraventricular tachycardia. Heart Rhythm 13:1283–1288 PubMedCrossRef
91.
Zurück zum Zitat Trucco SM, Jaeggi E, Cuneo B et al (2011) Use of intravenous gamma globulin and corticosteroids in the treatment of maternal autoantibody-mediated cardiomyopathy. J Am Coll Cardiol 57:715–723 PubMedCrossRef Trucco SM, Jaeggi E, Cuneo B et al (2011) Use of intravenous gamma globulin and corticosteroids in the treatment of maternal autoantibody-mediated cardiomyopathy. J Am Coll Cardiol 57:715–723 PubMedCrossRef
93.
Zurück zum Zitat Wakai RT, Strasburger JF, Li Z et al (2003) Magnetocardiographic rhythm patterns at initiation and termination of fetal supraventricular tachycardia. Circulation 107:307–312 PubMedCrossRef Wakai RT, Strasburger JF, Li Z et al (2003) Magnetocardiographic rhythm patterns at initiation and termination of fetal supraventricular tachycardia. Circulation 107:307–312 PubMedCrossRef
94.
95.
Zurück zum Zitat Willruth A, Steinhard J, Enzensberger C et al (2016) Fetal colour tissue Doppler imaging (cTDI): biventricular reference ranges for the time segments of the cardiac cycle in second and third trimesters of gestation. Arch Gynecol Obstet 294:917–924 PubMedCrossRef Willruth A, Steinhard J, Enzensberger C et al (2016) Fetal colour tissue Doppler imaging (cTDI): biventricular reference ranges for the time segments of the cardiac cycle in second and third trimesters of gestation. Arch Gynecol Obstet 294:917–924 PubMedCrossRef
Metadaten
Titel
Fetale Arrhythmien – ein Update
verfasst von
Prof. Dr. Ulrich Gembruch
Publikationsdatum
22.12.2021

Weitere Artikel der Ausgabe 1/2022

Die Gynäkologie 1/2022 Zur Ausgabe

Einführung zum Thema

Update fetale Echokardiographie

Medizinrecht

Medizinrecht

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.